Clinical trial
Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant Schizophrenia
NCT03585127
Study timeline
Study start (actual)2017-03-01Date precision: day
Registry last updated2020-07-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Auditory Hallucination, Verbalunresolved
Treatment-resistant Schizophreniaunresolved
Interventions
Cognitive Behavioral TherapyBEHAVIORAL
Avatar TherapyBEHAVIORAL
Sponsors & collaborators
Ciusss de L'Est de l'Île de Montréallead sponsor
Otsuka Canada Pharmaceutical Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03585127 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.